The Center for Applied Molecular Medicine (CAMM) is a multidisciplinary team of researchers dedicated to furthering the development and use of proteomic technologies to guide doctors in patient management decisions.
History of CAMM: In April 2009, Drs. Agus, Gross, Katz and Mallick initiated the CAMM at USC. The Center has been implemented in response to the observation that some patients experience long latent periods between diagnosis and symptomatic progression while others are afflicted with an aggressive and rapidly fatal form of the disease and the similar observation that some patients experience a complete clinical response to therapy while others will exhibit complete resistance. A technology to stratify patients according to molecular abnormalities and then apply this understanding to predict treatment responsiveness would represent an important step towards improving the care of patients. The program includes team members with expertise spanning cancer biology, biochemistry, molecular biology, bioinformatics, computer science, electrical engineering, bioorganic chemistry, statistical physics and applied mathematics.
David Agus, MD
Professor of Medicine and Engineering; Director, Lawrence J. Ellison Institute for Transformative Medicine of USC; Director, USC Norris Westside Cancer Center; Director, USC Center for Applied Molecular Medicine, Keck School of Medicine of USC and USC Viterbi School of Engineering
The Lawrence J. Ellison Institute for Transformative Medicine of USC aims to provide exceptional clinical care and to engender transformative changes in the management of cancer to significantly impact human health and well-being, and quantity and quality of life. We address important clinical questions through innovation and the integration of clinically driven science with applied engineering for the rigorous and rapid translation of novel technologies into clinical practice.